North Dakota State University
Label Free Micro-RNA Biomarker Detection in Serum Samples for Potential Diagnosis Application at Point-of-Care Settings
Abstract
dc:description.abstractThe number of new cancer cases is projected to rise to 23.6 million by 2030 according to the National Cancer Institute. Obesity & cardiovascular diseases are among the leading causes of death worldwide according to recent reports. Biomarkers— any molecules found within a human body that can be used to monitor an individual's health — have been shown to play a significant role in the detection of cancer, obesity, and cardiovascular diseases. Recent studies have shown that in the diagnosis and screening of various human diseases, including cancer, obesity and cardiovascular diseases, circulating microRNAs (miRNAs) are important biomarkers. A crucial roadblock to using microRNA in screening applications is the lack of effective and low-cost microRNA detection. To address this issue, in this study, we have developed a viable method that combines the dielectrophoresis and electrical impedance. Results show this approach can measure very small concentrations of label-free microRNAs (1pM).
Degree
thesis:*- Grantor dc:publisher
- North Dakota State University
- Year dc:date.issued
- 2020
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Pokharel, Rounak
- ORCID dc:identifier.orcid
Subjects
dc:subject × 4Rights
dc:rights- Statement dc:rights
-
- NDSU policy 190.6.2
- Licence dc:rights.uri
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/10365/31880